ConductScience.org, home

Paper55268

Tumour antigenicity in ovarian cancer.

Levin L and 3 others. Br J Cancer, 1975. Cited by 24 papers, by iCite.

Cite this record

ConductScience Library. Tumour antigenicity in ovarian cancer. Papers, record 55268. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/55268

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tumour antigenicity in ovarian cancer.
PubMed
Journal
Br J Cancer
PubMed
Year
1975
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
1.23
iCite
Revised in PubMed
2019-05-15
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Levin LL
2McHardy JEJ E
3Curling OMO M
4Hudson CNC N

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, NeoplasmMajor topic
Lymphocyte ActivationMajor topic
Ovarian NeoplasmsMajor topic
Adult
Aged
Epitopes
Female
Humans
In Vitro Techniques
Liver
Lung
Middle Aged
Ovary
Remission, Spontaneous

Source PubMed

Download CSV of topics

References11

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14514633Antigen solubilized from human solid tumours: lymphocyte stimulation and cutaneous delayed hypersensitivity.Nat New Biol1973https://conductscience.org/library/papers/4514633PubMed
24527605A common tumour specific antigen. II. Further characterization of the whole antigen and of a cross-reacting antigen of normal tissues.Br J Cancer1974https://conductscience.org/library/papers/4527605PubMed
34683045Lymphocyte reactivity in cancer patients: correlation with tumor histology and clinical stage.Cancer1973https://conductscience.org/library/papers/4683045PubMed
44717706Delayed cutaneous hypersensitivity reactions to extracts of malignant and normal breast cells.Ann Surg1973https://conductscience.org/library/papers/4717706PubMed
54821482Relation of cell-mediated immunity in women with genital tract cancer to origin, histology, clinical stage and subsequent behaviour of neoplasm.J Obstet Gynaecol Br Commonw1974https://conductscience.org/library/papers/4821482PubMed
64328010Tumor immunity in hamsters immunized with fetal tissues.J Immunol1971https://conductscience.org/library/papers/4328010PubMed
75559094Delayed cutaneous hypersensitivity reactions to membrane extracts of human tumour cells.Clin Exp Immunol1971https://conductscience.org/library/papers/5559094PubMed
94135399Ovarian tumor-specific antigens.Am J Obstet Gynecol1974https://conductscience.org/library/papers/4135399PubMed
104186861Antigenicity of a papillary serous cystadenocarcinoma tissue homogenate and its fractions.Am J Obstet Gynecol1969https://conductscience.org/library/papers/4186861PubMed
114317511Fetal antigen capable of inducing transplantation immunity against SV40 hamster tumor cells.J Immunol1970https://conductscience.org/library/papers/4317511PubMed
125125661Cell-mediated immune reaction to two gynecologic malignant tumors.Cancer1971https://conductscience.org/library/papers/5125661PubMed

Download CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
8505727Paraneoplastic syndromes in patients with ovarian neoplasia.J R Soc Med1993https://conductscience.org/library/papers/8505727PubMed
7437287Organ-related and malignancy-associated reactivity of cancer patients' leucocytes: a leucocyte migration study with tumour and foetal extracts.Br J Cancer1980https://conductscience.org/library/papers/7437287PubMed
7247268Victor Bonney Lecture, 1980. Ovarian cancer--a gynaecological disorder?Ann R Coll Surg Engl1981https://conductscience.org/library/papers/7247268PubMed
6965229Reaction of the leukocytes of melanoma patients and control donors, including pregnant women, with melanoma- and fetus-derived materials.Cancer Immunol Immunother1982https://conductscience.org/library/papers/6965229PubMed
6383602Activity of antibodies recovered from immune complexes of ovarian cancer patients.Cancer Immunol Immunother1984https://conductscience.org/library/papers/6383602PubMed
57789Tumour-associated immune responses and isolated carcinoembryonic antigen and alpha feto-protein levels related to survival in ovarian cancer patients.Br J Cancer1976https://conductscience.org/library/papers/57789PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/55268

GET https://conductscience.org/api/papers/v1/55268/authors